Versant Vantage I, L.P. is 10% Owner at Repare Therapeutics Inc. (RPTX). They have made 2 open-market trades across 2 companies since 2020, most recently 2025-09-19.
CIK 0001765253
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LVTX | SELL | 2025-09-19 | 2025-09-23 | $1.40 | $7.4M | +1.9% | +2.5% | N/A |
| RPTX | SELL | 2022-06-03 | 2022-06-07 | $12.25 | $6.1M | -8.2% | +7.9% | -17.0% |
| BDTX | SELL · 10b5-1 | 2020-11-19 | 2020-11-23 | $33.01 | $4.3M | -1.3% | -3.2% | -19.7% |
| BDTX | SELL · 10b5-1 | 2020-11-10 | 2020-11-12 | $34.11 | $1.4M | -2.8% | -1.9% | -19.3% |
| BDTX | SELL · 10b5-1 | 2020-11-06 | 2020-11-10 | $33.08 | $311K | -1.9% | +2.0% | -14.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.